HAE Key Stats
| Income Statement | |
| Revenue TTM | 891.99M |
| Revenue Quarterly YoY Growth | 33.90% |
| EPS Diluted TTM | 0.7454 |
| EPS Diluted Quarterly YoY Growth | -30.65% |
| Net Income TTM | 38.80M |
| Profitability | |
| Gross Profit Margin Quarterly | 49.27% |
| Profit Margin Quarterly | 5.03% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 2.118B |
| Enterprise Value | 2.425B |
| PE Ratio TTM | 55.02 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 2.753 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.6242 |
| Free Cash Flow | 8.712M |
| Return on Equity | 5.09% |
HAE News
- Interesting HAE Put For July 10:08 AM
- Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd., Interviews with ... May 17
- Haemonetics Corporation - Analyst/Investor Day Seeking Alpha May 16
- HAE Crosses Above Key Moving Average Level May 16
- Bargain Hunters Take Note: Insider Cluster-Buying At HAE May 8
- Insiders Buy the Holdings of XSLV May 6
- HAE Beats on Earnings, Revs in Line May 3
- HAE Beats on Earnings, Revs in Line - Analyst Blog Zacks May 3
- HAEMONETICS CORP Files SEC form 8-K/A, Results of Operations and Financial Condi... May 3
- Haemonetics Closes Hemerus Acquisition May 2
HAE Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Haemonetics Corporation is up 17.63% over the last year vs S&P 500 Total Return up 31.64%, Covidien up 25.97%, and NxStage Medical down 10.84%.
HAE Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Cash Flow Statement View Statement
You may also be interested in these HAE related companies
Pro Ratings for HAE
Pro Report PDF for HAE
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download HAE Pro Report PDF
Pro Strategies Featuring HAE
Did Haemonetics Corporation make it into our Pro Portfolio Strategies?
HAE Profile
Exchange: NYSE
Sector: Healthcare
Industry: Medical Instruments & Supplies
Other HAE Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HAE | 41.01 | -0.13 | -0.32% | 2.118B |
